Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood Pressure|August 18, 1999
The renin-angiotensin system in essential hypertension: associations with cardiovascular riskK Allikmets, T Parik, M Viigimaa
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Platelet aggregation, sensitivity to prostaglandin E1 and thromboxane A2 release in recombinant hirudin- and heparin-anticoagulated bloodM Viigimaa, D Tsikas, J C Frölich
Platelets|June 24, 2006
Effect of ciprofibrate on platelet aggregation in patients with combined hyperlipidemiaM Viigimaa, R Välkman, A Kask, et al.
Japanese Circulation Journal|June 1, 1993
Antithrombotic effect and reperfusion by low molecular weight heparin in a canine model of coronary artery thrombosisM Viigimaa, H Ohnogi, R Hattori, et al.
Platelets|November 4, 2010
Platelet Aggregation, Thromboxane A(2), Prostacyclin Generation and Platelet Sensitivity to Prostacyclin during the First Month after Myocardial InfarctionM Viigimaa, T Jôudu, U Keis, et al.
Upsala Journal of Medical Sciences|January 1, 1994
Antiaggregative therapy with acetylsalicylic acid and diclofenac in patients with acute myocardial infarctionM Viigimaa, T Jôudu, E Hendrikson, et al.
Physiological Measurement|September 20, 2014
Photoplethysmographic signal waveform index for detection of increased arterial stiffnessK Pilt, K Meigas, R Ferenets, et al.
Terapevticheskii Arkhiv|February 1, 2019
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseasesV Z Lankin, A K Tikhaze, M Viigimaa, et al.
Journal of Internal Medicine|December 11, 2002
Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and EstoniaJ Johansson, M Viigimaa, M Jensen-Urstad, et al.
International Journal of Clinical Practice|February 19, 2009
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS studyM Farnier, M Averna, L Missault, et al.
Pageof 2